Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 428106, 9 pages
http://dx.doi.org/10.1155/2015/428106
Research Article

The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis

1College of Basic Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
2Molecular Research in Traditional Chinese Medicine Group, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
3Department of Nephrology, Dongfang Hospital, The Second Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100078, China

Received 13 December 2014; Revised 23 February 2015; Accepted 12 March 2015

Academic Editor: Zhang Tan

Copyright © 2015 Lin Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Collins, R. N. Foley, B. Chavers et al., “United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States,” American Journal of Kidney Diseases, vol. 59, no. 1, supplement 1, p. A7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Tomas, “American Society of Nephrology renal research report,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 1886–1903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Cases and J. Mora-Macía, “Adrenomedullin: a new vasoactive peptide,” Nefrologia, vol. 21, no. 1, pp. 16–25, 2001. View at Google Scholar · View at Scopus
  4. J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto, “Adrenomedullin: a protective factor for blood vessels,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2480–2487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bełtowski and A. Jamroz, “Adrenomedullin—what do we know 10 years since its discovery?” Pharmacology, vol. 56, no. 1, pp. 5–27, 2004. View at Google Scholar · View at Scopus
  6. C.-Y. Ma, T.-G. Cui, and C.-S. Tang, “Protective effect of adrenomedullin on human renal tubulointerstitial lesion,” Basic Medical Sciences and Clinics, vol. 21, no. 2, pp. 151–153, 2001. View at Google Scholar
  7. J.-G. Qin, L. Han, Y.-H. Wang et al., “Action mechanism of Tongmai Yishen Fang in antagonism of renal interstitial fibrosis,” Journal of Beijing University of Traditional Chinese Medicine, vol. 35, no. 11, pp. 739–742, 2012. View at Google Scholar
  8. S.-Q. Li, X.-M. Liu, and W.-Z. Wang, “The research study of Salvia miltiorrhiza effects on hypertension nephrosclerosis rats,” Chinese Archives of Traditional Chinese Medicine, vol. 24, no. 2, pp. 224–225, 2006. View at Google Scholar
  9. W.-Z. Zou, “Instruction on pathologic diagnostic criteria of renal biopsy,” Chinese Journal of Nephrology, vol. 17, no. 4, pp. 270–275, 2001. View at Google Scholar
  10. I. Mimura and M. Nangaku, “The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease,” Nature Reviews Nephrology, vol. 6, no. 11, pp. 667–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. “Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions,” The New England Journal of Medicine, vol. 327, no. 10, pp. 685–691, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. B. M. Brenner, M. E. Cooper, D. de Zeeuw et al., “Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy,” The New England Journal of Medicine, vol. 345, no. 12, pp. 861–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Fliser, “Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease,” Journal of Nephrology, vol. 23, no. 4, pp. 369–376, 2010. View at Google Scholar · View at Scopus
  14. H.-T. Kuo, S.-J. Shin, M.-C. Kuo, and H.-C. Chen, “Effects of specific endothelin-1 receptor antagonists on proliferation and fibronectin production of glomerular mesangial cells stimulated with angiotensin II,” Kaohsiung Journal of Medical Sciences, vol. 22, no. 8, pp. 371–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. T. Tang, D. S. Cheng, Y. T. Jia et al., “Angiotensin II induces type I collagen gene expression in human dermal fibrovlasts through an AP-1 /TCF-β1-dependent pathway,” Biochemical and Biophysical Research Communications, vol. 385, no. 3, pp. 418–423, 2009. View at Google Scholar
  16. P. Minuz, P. Patrignani, S. Gaino et al., “Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease,” Circulation, vol. 106, no. 22, pp. 2800–2805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Polichnowski, C. Jin, C. Yang, and A. W. Cowley, “Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats,” Hypertension, vol. 55, no. 6, pp. 1425–1430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Bouvier, J. P. Flinois, J. Gilleron et al., “Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death,” The American Journal of Physiology—Renal Physiology, vol. 296, no. 1, pp. F160–F169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P.-X. Xu, H. Li, and Z.-Y. Sun, “Expression of vascular endothelial growth factor in myocardium of spontaneously hypertensive rats,” Medical Journal of the Chinese People's, vol. 16, no. 7, pp. 491–493, 2005. View at Google Scholar
  20. S.-L. Wang and Z.-B. Zhang, “Apoptosis of vascular endothelial cells,” Journal of Liaoning University of TCM, vol. 13, no. 3, pp. 50–53, 2011. View at Google Scholar
  21. F. Yoshihara, S.-I. Suga, N. Yasui et al., “Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats,” Regulatory Peptides, vol. 128, no. 1, pp. 7–13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Shimekake, K. Nagata, S. Ohta et al., “Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells,” The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4412–4417, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Horio, M. Kohno, H. Kano et al., “Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells,” Circulation Research, vol. 77, no. 4, pp. 660–664, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kohno, K. Yokokawa, H. Kano et al., “Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells,” Hypertension, vol. 29, no. 6, pp. 1309–1313, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. H. K. Wong, T. T. Cheung, and B. M. Y. Cheung, “Adrenomedullin and cardiovascular diseases,” JRSM Cardiovascular Disease, vol. 1, no. 5, article 14, 7 pages, 2012. View at Publisher · View at Google Scholar
  26. K. Miyashita, H. Itoh, N. Sawada et al., “Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo,” FEBS Letters, vol. 544, no. 1–3, pp. 86–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. E. Hermansen, T. Lund, T. Kalstad, K. Ytrehus, and T. Myrmel, “Adrenomedullin augments the angiogenic potential of late outgrowth endothelial progenitor cells,” American Journal of Cell Physiology, vol. 300, no. 4, pp. C783–C791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Tsuruda, J. Kato, Y.-N. Cao et al., “Adrenomedullin induces matrix metalloproteinase-2 activity in rat aortic adventitial fibroblasts,” Biochemical and Biophysical Research Communications, vol. 325, no. 1, pp. 80–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. X.-X. Zhu, D. Yan, S.-H. Yan et al., “Empirical study of Jiang ya Yi shen particles on ET-1 and TGF-β1 expression in spontaneously hypertensive rats (SHR),” Chinese Archives of Traditional Chinese Medicine, vol. 28, no. 9, pp. 1805–1806, 2010. View at Google Scholar
  30. I. J. Cho, C. Lee, and T. Y. Ha, “Hypolipidemic effect of soluble fiber isolated from seeds of cassia tora Linn. In rats fed a high-cholesterol diet,” Journal of Agricultural and Food Chemistry, vol. 55, no. 4, pp. 1592–1596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Ma, Z. Chen, and Y. Wang, “The clinical observation of treatment of hypertensive renal injury edema by combination of fangjihuangqi decoction and western medicine,” Chinese Journal of Basic Medicine in Traditional Chinese Medicine, vol. 18, no. 8, pp. 879–880, 2012. View at Google Scholar
  32. H.-Q. Tao, J. Li, J. Zhang et al., “The curative effect observation of treatment of early stage in hypertensive renal injury by combination of Liuwei Dihuang Wan and western medicine,” Shaanxi Journal of Traditional Chinese Medicine, vol. 33, no. 4, pp. 411–412, 2012. View at Google Scholar
  33. W. Zheng and S.-Q. Li, “The effect of tongxinluo on blood vessel endothelium in spontaneously hypertension rat,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 7, no. 2, pp. 179–180, 2009. View at Publisher · View at Google Scholar
  34. Z. Jan, Y.-B. Li, D.-W. Qian et al., “Chrysanthemum chemical components and pharmacological activity research progress,” Lishizhen Medicine and Materia Medica Research, vol. 17, no. 10, pp. 1941–1942, 2006. View at Google Scholar
  35. R. Tang, Q.-L. Zhou, P. Veeraragoo, Z. Xiao, and Z. Liu, “Effects of cordyceps sinensis on renal Klotho expression and oxidative stress in spontaneously hypertensive rats,” Chinese Journal of Nephrology Dialysis & Transplantation, vol. 19, no. 4, pp. 338–343, 2010. View at Google Scholar
  36. J.-G. Qin, Y.-H. Wang, J.-P. Liang et al., “Weiqin Guo's treatment experience about hypertension,” Journal of Traditional Chinese Medicine, vol. 48, no. 7, pp. 586–589, 2007. View at Google Scholar
  37. T. Ishimitsu, T. Nishikimi, Y. Saito et al., “Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure,” Journal of Clinical Investigation, vol. 94, no. 5, pp. 2158–2161, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kohno, T. Hanehira, H. Kano et al., “Plasma adrenomedullin concentrations in essential hypertension,” Hypertension, vol. 27, no. 1, pp. 102–107, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Braam, K. D. Mitchell, J. Fox, and L. G. Navar, “Proximal tubular secretion of angiotensin II in rats,” The American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 264, no. 5, part 2, pp. F891–F898, 1993. View at Google Scholar · View at Scopus
  40. M. Bader, J. Peters, O. Baltatu, D. N. Müller, F. C. Luft, and D. Ganten, “Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research,” Journal of Molecular Medicine, vol. 79, no. 2, pp. 76–102, 2001. View at Publisher · View at Google Scholar · View at Scopus